{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:03:12Z","timestamp":1761519792376,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.3816\/ccc.2009.n.024","type":"journal-article","created":{"date-parts":[[2009,7,25]],"date-time":"2009-07-25T21:06:12Z","timestamp":1248555972000},"page":"146-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Polymorphisms in the Enhancer Region of the Thymidylate Synthase Gene Are Associated with Thymidylate Synthase Levels in Normal Tissues but Not in Malignant Tissues of Patients with Colorectal Cancer"],"prefix":"10.3816","volume":"8","author":[{"given":"Robert","family":"Mauritz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines J.","family":"Beumer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kees","family":"Smid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees J.","family":"Van Groeningen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert M.","family":"Pinedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godefridus J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CCC.2009.n.024_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra040958","article-title":"Systemic therapy for colorectal cancer","volume":"352","author":"Meyerhardt","year":"2005","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2009.n.024_bib2","series-title":"Anticancer Drug Development Guide: Antifolate Drugs in Cancer Therapy","first-page":"409","article-title":"The role of uracil misincorporation in thymineless death","author":"Aherne","year":"1999"},{"key":"10.3816\/CCC.2009.n.024_bib3","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/nar\/15.3.1259","article-title":"Role in translation of a triple tandemly repeated sequence in the 5\u2032-untranslated region of human thymidylate synthase mRNA","volume":"15","author":"Kaneda","year":"1987","journal-title":"Nucleic Acids Res"},{"key":"10.3816\/CCC.2009.n.024_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1247\/csf.20.191","article-title":"Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5\u2032-terminal regulatory region of the human gene for thymidylate synthase","volume":"20","author":"Horie","year":"1995","journal-title":"Cell Struct Funct"},{"key":"10.3816\/CCC.2009.n.024_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/157016006776055419","article-title":"Pharmacogenetics of colon cancer and potential implications for 5-fluorouracil-based chemotherapy","volume":"4","author":"Mauritz","year":"2006","journal-title":"Curr Pharmacogenomics"},{"key":"10.3816\/CCC.2009.n.024_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.tpj.6500012","article-title":"Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy","volume":"1","author":"Pullarkat","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"10.3816\/CCC.2009.n.024_bib7","first-page":"3875","article-title":"Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer","volume":"24","author":"Calascibetta","year":"2004","journal-title":"Anticancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib8","first-page":"4096","article-title":"Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression","volume":"7","author":"Kawakami","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib9","first-page":"2805","article-title":"Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer","volume":"22","author":"Ishida","year":"2002","journal-title":"Anticancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib10","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1200\/JCO.2002.09.091","article-title":"Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses","volume":"20","author":"Etienne","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2009.n.024_bib11","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.1994.12.10.2035","article-title":"Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil","volume":"12","author":"Peters","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2009.n.024_bib12","first-page":"1322","article-title":"Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase","volume":"6","author":"Salonga","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib13","first-page":"383","article-title":"Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer","volume":"19","author":"Marsh","year":"2001","journal-title":"Int J Oncol"},{"key":"10.3816\/CCC.2009.n.024_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1054\/bjoc.2001.2007","article-title":"A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil","volume":"85","author":"Iacopetta","year":"2001","journal-title":"Br J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1200\/JCO.2001.19.6.1779","article-title":"Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer","volume":"19","author":"Villafranca","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2009.n.024_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s003840100358","article-title":"Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer","volume":"17","author":"Park","year":"2002","journal-title":"Int J Colorectal Dis"},{"key":"10.3816\/CCC.2009.n.024_bib17","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1200\/JCO.2006.10.4182","article-title":"Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group","volume":"26","author":"Schwab","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2009.n.024_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2008.03.025","article-title":"Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer","author":"Martinez-Balibrea","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib19","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1158\/1078-0432.CCR-04-0169","article-title":"Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy","volume":"10","author":"Lecomte","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib20","first-page":"3700","article-title":"Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer","volume":"9","author":"Tsuji","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1158\/1078-0432.CCR-07-0425","article-title":"Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients","volume":"14","author":"Sharma","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ijc.20487","article-title":"Single nucleotide polymorphism in the 5\u2032 tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients","volume":"112","author":"Marcuello","year":"2004","journal-title":"Int J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/sj.bjc.6604555","article-title":"Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracilbased chemotherapy","volume":"99","author":"Graziano","year":"2008","journal-title":"Br J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib24","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.ejca.2005.06.016","article-title":"Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers","volume":"41","author":"Morganti","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2217\/14622416.8.8.985","article-title":"C SNP of thymidylate synthase with respect to colorectal cancer","volume":"8","author":"Gusella","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.3816\/CCC.2009.n.024_bib26","first-page":"2898","article-title":"A novel single nucleotide polymorphism within the 5\u2032 tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity","volume":"63","author":"Mandola","year":"2003","journal-title":"Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00008571-200405000-00007","article-title":"A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratu-moral TS mRNA levels","volume":"14","author":"Mandola","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.3816\/CCC.2009.n.024_bib28","first-page":"6004","article-title":"Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene","volume":"63","author":"Kawakami","year":"2003","journal-title":"Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0925-4439(02)00082-0","article-title":"Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism","volume":"1587","author":"Peters","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.3816\/CCC.2009.n.024_bib30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/geno.1999.5833","article-title":"Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations","volume":"58","author":"Marsh","year":"1999","journal-title":"Genomics"},{"key":"10.3816\/CCC.2009.n.024_bib31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ejca.2006.12.012","article-title":"Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel","volume":"43","author":"Nief","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib32","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1158\/1078-0432.CCR-04-2428","article-title":"Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy","volume":"11","author":"Kawakami","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bjc.6603639","article-title":"Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels","volume":"96","author":"Giovannetti","year":"2007","journal-title":"Br J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2217\/14622416.6.8.873","article-title":"Concordance of pharmacogenetic markers in germline and colorectal tumor DNA","volume":"6","author":"Marsh","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.3816\/CCC.2009.n.024_bib35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/01.fpc.0000230410.07899.bc","article-title":"Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients","volume":"16","author":"Amatori","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.3816\/CCC.2009.n.024_bib36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ijc.21692","article-title":"5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis","volume":"119","author":"Kuramochi","year":"2006","journal-title":"Int J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib37","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1081\/NCN-200027634","article-title":"Polymorphisms of the thymidylate synthase gene and thymidylate synthase levels in colon cancer cell lines and different tissues of colorectal cancer patients","volume":"23","author":"Mauritz","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.3816\/CCC.2009.n.024_bib38","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1002\/ijc.22235","article-title":"The thymidylate synthase tandem repeat promoter polymorphism: A predictor for tumor-related survival in neoadjuvant treated locally advanced gastric cancer","volume":"119","author":"Ott","year":"2006","journal-title":"Int J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib39","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2005.06.219","article-title":"Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity","volume":"23","author":"Jakobsen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2009.n.024_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ijc.2910470507","article-title":"Activity of thymidylate synthetase, thymidine kinase and galactokinase in primary and xenografted human colorectal cancers in relation to their chromosomal patterns","volume":"47","author":"Bardot","year":"1991","journal-title":"Int J Cancer"},{"key":"10.3816\/CCC.2009.n.024_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/jcp.55.3.206","article-title":"Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases","volume":"55","author":"Backus","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.3816\/CCC.2009.n.024_bib42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4161\/cbt.2.4.424","article-title":"A novel function for the rTS gene","volume":"2","author":"Dolnick","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.3816\/CCC.2009.n.024_bib43","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.0308716101","article-title":"Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients","volume":"101","author":"Wang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3816\/CCC.2009.n.024_bib44","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1158\/0008-5472.CAN-06-2165","article-title":"Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy","volume":"66","author":"Brody","year":"2006","journal-title":"Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib45","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1349-7006.2002.tb01227.x","article-title":"Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity","volume":"93","author":"Kawakami","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"10.3816\/CCC.2009.n.024_bib46","series-title":"Anticancer Drug Development Guide: Antifolate Drugs in Cancer Therapy","first-page":"397","article-title":"Molecular regulation of expression of thymidylate synthase","author":"Chu","year":"1999"},{"key":"10.3816\/CCC.2009.n.024_bib47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s004320050111","article-title":"5-fluorouracil\/leucovorininduced inhibition of thymidylate synthase in normal tissues of mouse and man","volume":"123","author":"Van der Wilt","year":"1997","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.3816\/CCC.2009.n.024_bib48","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1200\/JCO.2007.15.5481","article-title":"Predicting fluorouracil toxicity: can we finally do it?","volume":"26","author":"Ezzeldin","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811703632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811703632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:59:47Z","timestamp":1761519587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002811703632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1533002811703632"],"URL":"https:\/\/doi.org\/10.3816\/ccc.2009.n.024","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphisms in the Enhancer Region of the Thymidylate Synthase Gene Are Associated with Thymidylate Synthase Levels in Normal Tissues but Not in Malignant Tissues of Patients with Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CCC.2009.n.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}